UK investigates HIV/AIDS device cure claims
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued an alert concerning a probable scam involving claims that a medical device can cure HIV/AIDS, among other conditions. The ongoing police investigation is centred around a website under the name of Savec Health Systems, claiming that the device and associated medication has been used successfully in a number of Northern Ireland clinics and can be supplied to the public, subject to an online payment. "It would be extremely doubtful that any machine of this kind would have any value in the treatment of HIV/AIDS," said MHRA policy director Shaun Gallagher. "The evidence suggests that the product does not even exist and that this is simply a scam."
You may also be interested in...
With business heavily dependent on sales revenue from Medicare Part D and other US government programs, Lilly will be expected to narrow the gap between US prescription and sales growth.
MDSAP And USMCA: 3 Ways Mexico Can To Come Up-To-Speed With The Single-Audit Program Targeted By New Free-Trade Accord
The US-Mexico-Canada (USMCA) treaty calls for the three countries to “recognize audits” performed under the Medical Device Single Audit Program. MDSAP is already used by device makers in the US and Canada so they can undergo one audit by an accredited third party to satisfy quality regulations. That leaves Mexico as the odd country out when it comes to using the popular program – and that means it has some catching up to do after the USMCA is ratified by all three nations. Former longtime FDA official Kim Trautman weighs in on how Mexico can incorporate MDSAP into its regulatory framework.
Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.